Celularity Inc. (CELU) vs TELA Bio, Inc. (TELA)

A side-by-side comparison of Celularity Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CELU vs TELA

growth of $100 · dividends reinvested · last 7y
CELU -98.3% (-44.0%/yr)TELA -91.5% (-29.6%/yr)TELA compounded faster over this window
050100150Start $100202120232025$2$9
CELU TELA

CELU vs TELA: by the numbers

  • •TELA is the larger company ($49M vs $45M market cap).
  • •Both run net losses; TELA's is the smaller (-51.53% vs -375.77% net margin).
  • •TELA grew revenue faster over the past five years (26.77% vs 8.31% CAGR).

Metrics side by side

Valuation

MetricCELUTELA
P/S ratio2.390.61

Profitability

MetricCELUTELA
Gross margin79.62%67.81%
Operating margin-230.92%-42.56%
Net margin-375.77%-51.53%
ROIC-192.99%-80.88%

Growth (annualized)

MetricCELUTELA
Revenue CAGR (5Y)8.31%26.77%
Total return CAGR (5Y)-52.57%-38.71%

Frequently asked

Which has grown faster, CELU or TELA?
Over the past five years, TELA grew revenue faster — CELU at a 8.31% CAGR versus TELA at 26.77%.
How have CELU and TELA total returns compared?
Over the past 5 years, CELU delivered -52.57% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.